Fig. 2From: The contribution of single-cell analysis of acute leukemia in the therapeutic strategyA: when no Poor Prognosis Markers (PPM) are detected, classical poly-chemotherapy may attain CR and possibly definitive AML cure, B: even in the presence of PPM, if these PPM are evenly distributed between AML blasts, conventional chemotherapy + targeted therapy against residual AML cells may allow leukemia cureBack to article page